News

Future development, will continue to strengthen the core competitiveness of the building, so that the company's research and development has always been in line with the international frontier.

  • Product
  • Antiviral
  • Liver
  • Tumor
  • Breathing
  • Antibiotic
  • Hypoglycemic
  • Bone
  • Digestion
  • Product

    Treatment involves liver disease, cancer, diabetes, respiratory, cardiovascular and cerebrovascular diseases, anti infection, digestive, nervous and other diseases.

  • Innovate
  • Responsibility
  • Idea
  • Commonweal
  • Development
  • Presentation
  • Responsibility

  • Job
  • Contact Us
  • News

  • 07 2017-01
    China's health industry is forecast to be 4 trillion and 900...

      institutions predict that in 2017 the scale of China's health industry was 4 trillion and 900...

  • 07 2017-01
    Medical insurance settlement in the province to achieve a lo...

      medical insurance settlement in the province has been fully realized. Ministry of human resou...

  • 07 2017-01
    Opinions on reforming the management system of social organi...

    Recently, the office of the CPC Central Committee and the State Council issued the "on the reform of...

  • 07 2017-01
    28 departments issued a memorandum of cooperation: Joint Dis...

    According to the State Food and Drug Administration website news, the 28 departments of the State De...

  • Innovate

  • Future product Future product

    In the research of more than 200 products, focus on liver disease, tumor, anti infection, respiratory and hypoglycemic etc..

    View Details
  • R & D results R & D results

    The patent application of more than 400 national, provincial major science and technology projects of more than 50.

    View Details
  • Scientific research cooperation Scientific research cooperation

    Shanghai Medical Institute and other units to cooperate to establish 5 joint laboratories, reached a number of international and domestic cooperation

    View Details
  • Research and development overview Research and development overview

    Research Institute under the Nanjing branch, Lianyungang branch, national enterprise technology center has a number of high-level R & D platform.

    View Details
  • Responsibility

  • <i>2015</i>CSR

    2015CSR

    Pharmaceutical Group Social Responsibility Report
    Corporation Social Responsibility Report

    View Details
  • Product
  • Antiviral
  • Liver
  • Tumor
  • Breathing
  • Antibiotic
  • Hypoglycemic
  • Bone
  • Digestion
  • Innovate
  • Responsibility
  • Idea
  • Commonweal
  • Development
  • Presentation
  • Share:
  • Scan access phone WeChat

  • WeChat public number